Autologous versus allogeneic: how cell therapy development is changing in oncology

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
EurekAlert!

Unveiling the complexity of G protein-coupled receptor heteromers: advances in live cell imaging technologies and biochemical methods

The discovery of G protein-coupled receptor (GPCR) heteromers has revealed a new level of complexity in their functional characteristics. This review explores a variety of methodologies and live cell ...
Frontiers

Community Series in 'Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics' Volume II

This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...
Nature

Genomic clues to the origin of eukaryotic cells

John M. Archibald is in the Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada, and also at the Institute for Comparative Genomics, Dalhousie ...